Fuhrman, Dana Y. https://orcid.org/0000-0002-3672-7960
Bagshaw, Sean M.
Goldstein, Stuart L.
Legrand, Matthieu
Shaw, Andrew D.
Article History
Accepted: 6 August 2024
First Online: 15 August 2024
Declarations
:
: SMB has received fees for scientific advisory from Baxter, bioMerieux, BioPorto, Novartis, Sea Star Medical, SphingoTec.; SLG has received grant support from BioPorto Diagnostics, Baxter, NuWellis, ExThera Medical, SeaStar Medical, Roche, Otsuka and consulting fees from BioPorto Diagnostics, Baxter, NuWellis, SeaStar Medical, Talphera, Otsuka, Calcimedica, Fresenius. He has ownership interest in MediBeacon Inc. and receives licensing revenues from RAIDAR Health; the remaining authors declare no potential competing interests.